However, information on the changes in circulating CRELD2 levels in ER stress-related diseases, including diabetes, obesity, inflammation, NAFLD, CVDs, kidney diseases, and cancer, is still lacking. Here, CRELD2 is linked to metabolic dysfunction-associated steatotic liver disease.